Correlation Between Virax Biolabs and Orchestra BioMed

Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virax Biolabs Group and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Virax Biolabs and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Orchestra BioMed.

Diversification Opportunities for Virax Biolabs and Orchestra BioMed

0.26

Correlation Coefficient

Virax Biolabs  Orchestra BioMed

Modest diversification

The 3 months correlation between Virax and Orchestra is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Virax Biolabs and Orchestra BioMed

Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.57 times more return on investment than Orchestra BioMed. However, Virax Biolabs is 1.57 times more volatile than Orchestra BioMed Holdings. It trades about 0.26 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about 0.05 per unit of risk. If you would invest  184.00  in Virax Biolabs Group on October 9, 2024 and sell it today you would earn a total of  127.00  from holding Virax Biolabs Group or generate 69.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Virax Biolabs Group  vs.  Orchestra BioMed Holdings

Virax Biolabs Group

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.

Orchestra BioMed Holdings

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Orchestra BioMed Holdings are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Orchestra BioMed displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Virax Biolabs and Orchestra BioMed

The main advantage of trading using opposite Virax Biolabs and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.

The idea behind Virax Biolabs Group and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.